Physician profile
Michael Nagy
NPI 1619913746
$27,383.69
in general payments reported to CMS, 2019-2025
11 companies · $3,277 in 2025
The $3,277 reported for 2025 was more than what 89% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,470 · 2020: $415 · 2021: $6,943 · 2022: $3,931 · 2023: $2,901 · 2024: $2,447 · 2025: $3,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,320 · Food and Beverage: $3,189 · Travel and Lodging: $703 · Long Term Medical Supply Or Device Loan: $326 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,319.75 |
| Food and Beverage | $3,189.19 |
| Travel and Lodging | $703.32 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $9,941.82 | 2019-2024 | Xeomin |
| Allergan, INC. | $9,892.75 | 2019-2023 | |
| Abbvie INC. | $4,497.08 | 2023-2025 | |
| Motiva USA, LLC | $1,490.68 | 2025 | |
| Revance Therapeutics, INC. | $475.11 | 2024-2025 | Daxxify |
| Integra Lifesciences Corporation | $339.05 | 2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Sientra, INC. | $295.50 | 2022 | |
| Mentor Worldwide LLC | $192.07 | 2020-2021 | |
| Acera Surgical, INC. | $160.85 | 2024 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $81.83 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $16.95 | 2024 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.